Narayan Prabhu
2023
In 2023, Narayan Prabhu earned a total compensation of $1.2M as Chief Financial Officer at REVIVA PHARMACEUTICALS HOLDINGS, a 203% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $95,940 |
|---|---|
| Option Awards | $827,838 |
| Salary | $325,000 |
| Total | $1,248,778 |
Prabhu received $827.8K in option awards, accounting for 66% of the total pay in 2023.
Prabhu also received $95.9K in non-equity incentive plan and $325K in salary.
Rankings
In 2023, Narayan Prabhu's compensation ranked 942nd out of 2,770 executives tracked by ExecPay. In other words, Prabhu earned more than 66.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 942 out of 2,770 | 66th |
Division Manufacturing | 562 out of 1,516 | 63rd |
Major group Chemicals And Allied Products | 386 out of 855 | 55th |
Industry group Drugs | 375 out of 821 | 54th |
Industry Pharmaceutical Preparations | 254 out of 590 | 57th |
Source: SEC filing on October 28, 2024.
Prabhu's colleagues
We found one more compensation record of an executive who worked with Narayan Prabhu at REVIVA PHARMACEUTICALS HOLDINGS in 2023.
2023
Laxminarayan Bhat
REVIVA PHARMACEUTICALS HOLDINGS